Austin Che

Founder, Ginkgo BioWorks Inc

Role: Associate

Site: CDL-Toronto

Stream: Matter

Austin Che is a co-founder of Ginkgo Bioworks, which is building the leading horizontal platform for synthetic biology, making it possible to program cells as easily as we can program computers and enabling innovation across industries, including therapeutics, industrials, food and agriculture. Ginkgo Bioworks expects to go public in 2021 via a merger with Soaring Eagle Acquisition Corp. at a $15 billion pre-money valuation. He has a PhD in Computer Science and Synthetic Biology from MIT.